Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by Njdevilsfanon Jul 18, 2017 11:53am
116 Views
Post# 26481413

RE:RE:Actually a little surprised to see it under the 50 DMA....

RE:RE:Actually a little surprised to see it under the 50 DMA....i disagree. it's prudent for them to raise given the significant increase in the share price. it's always good to be in a strong financial position. the money will help with the launch, continue with business activities and perhaps be used for an acqusition. you raise money when you can in this market. although i believe fda approval is almost a certainty, what happens if there is a CRL and stock tanks? the company has to ensure they have the finances to continue. i have no trouble with a financing if that were to happen. i am hoping it's somewhat minimal but i understand. i use to own TRIL and many people were hoping they would raise more capital when the stock was in the upper teens/lower $20's. the company chose not to raise and then months later, the stock was at $7. they raised then. they must have been kicking themselves for not raising when the stock price was much higher. one of the bigger knocks on companies is their cash position. i have no problem knowing therf has plenty of coin in the bank
Bullboard Posts